In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.

Source:http://linkedlifedata.com/resource/pubmed/id/19625168

Download in:

View as

General Info

PMID
19625168